Sci Pharmtech Inc

TPE:4119 (Taiwan)  
NT$ 90.30 (+0.11%) Jun 21
39.50
P/B:
2.10
Market Cap:
NT$ 10.79B ($ 333.42M)
Enterprise V:
NT$ 10.83B ($ 334.51M)
Volume:
136.10K
Avg Vol (2M):
201.80K
Trade In:
Volume:
136.10K
Avg Vol (2M):
201.80K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Sci Pharmtech Inc ( TPE:4119 ) from 2004 to Jun 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sci Pharmtech stock (TPE:4119) PE ratio as of Jun 24 2024 is 39.5. More Details

Sci Pharmtech Inc (TPE:4119) PE Ratio (TTM) Chart

To

Sci Pharmtech Inc (TPE:4119) PE Ratio (TTM) Historical Data

Total 1221
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Sci Pharmtech PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-24 39.5 2024-04-18 38.6
2024-06-21 39.5 2024-04-17 38.7
2024-06-20 39.5 2024-04-16 38.2
2024-06-19 39.5 2024-04-15 38.4
2024-06-18 39.5 2024-04-12 38.7
2024-06-17 39.7 2024-04-11 38.9
2024-06-14 39.4 2024-04-10 39.1
2024-06-13 39.4 2024-04-09 38.9
2024-06-12 39.5 2024-04-08 38.5
2024-06-11 39.5 2024-04-03 38.4
2024-06-07 40.7 2024-04-02 38.8
2024-06-06 40.4 2024-04-01 38.8
2024-06-05 40.6 2024-03-29 38.6
2024-06-04 40.5 2024-03-28 38.6
2024-06-03 40.4 2024-03-27 34.9
2024-05-31 40.2 2024-03-26 34.8
2024-05-30 40.5 2024-03-25 35.0
2024-05-29 40.4 2024-03-22 35.0
2024-05-28 40.5 2024-03-21 35.0
2024-05-27 40.7 2024-03-20 35.0
2024-05-24 40.2 2024-03-19 35.1
2024-05-23 39.9 2024-03-18 34.7
2024-05-22 40.4 2024-03-15 34.9
2024-05-21 40.3 2024-03-14 34.8
2024-05-20 40.9 2024-03-13 35.1
2024-05-17 41.1 2024-03-12 35.5
2024-05-16 40.5 2024-03-11 35.5
2024-05-15 40.0 2024-03-08 36.1
2024-05-14 39.9 2024-03-07 36.1
2024-05-13 40.2 2024-03-06 36.3
2024-05-10 39.8 2024-03-05 36.3
2024-05-09 38.7 2024-03-04 36.3
2024-05-08 38.9 2024-03-01 36.5
2024-05-07 38.5 2024-02-29 36.4
2024-05-06 38.7 2024-02-27 36.5
2024-05-03 38.7 2024-02-26 36.8
2024-05-02 38.9 2024-02-23 36.4
2024-04-30 38.9 2024-02-22 36.4
2024-04-29 39.0 2024-02-21 36.4
2024-04-26 38.9 2024-02-20 36.3
2024-04-25 38.7 2024-02-19 36.5
2024-04-24 38.4 2024-02-16 36.1
2024-04-23 38.4 2024-02-15 35.9
2024-04-22 37.8 2024-02-09 36.4
2024-04-19 37.8 2024-02-08 36.4

Sci Pharmtech Inc (TPE:4119) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Sci Pharmtech Inc is engaged in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals. Geographically, the primary markets of the company are Italy, Germany, Japan, Taiwan, the United States, China, Switzerland, Spain, and others.